358 related articles for article (PubMed ID: 18184173)
1. Transitional cell carcinoma in renal transplant recipients: a single center experience.
Li XB; Xing NZ; Wang Y; Hu XP; Yin H; Zhang XD
Int J Urol; 2008 Jan; 15(1):53-7. PubMed ID: 18184173
[TBL] [Abstract][Full Text] [Related]
2. Transitional cell carcinoma in renal transplant recipients.
Liao CH; Chueh SC; Lai MK; Chen J
Transplant Proc; 2004 Sep; 36(7):2152-3. PubMed ID: 15518781
[TBL] [Abstract][Full Text] [Related]
3. [Clinical character of renal transplant recipients with bilateral native upper urinary transitional cell carcinoma].
Zhang P; Wang Y; Zhang XD; Hu XP; Wang W; Zhang Y; Yin H
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):248-50. PubMed ID: 19552841
[TBL] [Abstract][Full Text] [Related]
4. Urological malignancy as a complication of renal transplantation: a report of twelve clinical cases.
Zhou M; Zhu Y; Wang L; Wang Y; Fu S; Min Z
Clin Transpl; 2006; ():395-8. PubMed ID: 18365395
[TBL] [Abstract][Full Text] [Related]
5. Nephrogenic adenoma of the bladder in renal transplant and non-renal transplant patients: a review of 22 cases.
Tse V; Khadra M; Eisinger D; Mitterdorfer A; Boulas J; Rogers J
Urology; 1997 Nov; 50(5):690-6. PubMed ID: 9372876
[TBL] [Abstract][Full Text] [Related]
6. [De novo urological neoplasms in kidney transplant patients: experience in 1,751 patients].
di Capua Sacoto C; Luján Marco S; Bahilo Mateu P; Budía Alba A; Pontones Moreno JL; Jiménez Cruz JF
Actas Urol Esp; 2010 Jan; 34(1):88-94. PubMed ID: 20223138
[TBL] [Abstract][Full Text] [Related]
7. The management of transitional cell carcinoma (TCC) in a European regional renal transplant population.
Rogers A; Ng JK; Glendinning J; Rix D
BJU Int; 2012 Jul; 110(2 Pt 2):E34-40. PubMed ID: 22243691
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic management of de novo urological malignancy in renal transplant recipients: the experience of the French Department of Urology and Kidney Transplantation from Bordeaux.
Elkentaoui H; Robert G; Pasticier G; Bernhard JC; Couzi L; Merville P; Ravaud A; Ballanger P; Ferrière JM; Wallerand H
Urology; 2010 Jan; 75(1):126-32. PubMed ID: 19864001
[TBL] [Abstract][Full Text] [Related]
9. Unusual clinical presentation of upper urothelial carcinoma in Taiwan.
Chou YH; Huang CH
Cancer; 1999 Mar; 85(6):1342-4. PubMed ID: 10189140
[TBL] [Abstract][Full Text] [Related]
10. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
Chou EC; Lin AT; Chen KK; Chang LS
Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
[TBL] [Abstract][Full Text] [Related]
11. Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan.
Chang CH; Yang CM; Yang AH
Cancer; 2007 Apr; 109(8):1487-92. PubMed ID: 17330839
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of hand-assisted laparoscopic nephroureterectomy for managing upper urinary tract transitional cell carcinoma--China Medical University Hospital experience.
Chen CH; Wu HC; Chen WC; Yeh CC; Chen CC; Chang CH
Urology; 2005 Apr; 65(4):687-91. PubMed ID: 15833509
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for intravesical recurrence after surgical management of transitional cell carcinoma of the upper urinary tract.
Terakawa T; Miyake H; Muramaki M; Takenaka A; Hara I; Fujisawa M
Urology; 2008 Jan; 71(1):123-7. PubMed ID: 18242379
[TBL] [Abstract][Full Text] [Related]
14. Renal cell and transitional cell carcinoma in a Japanese population undergoing maintenance dialysis.
Satoh S; Tsuchiya N; Habuchi T; Ishiyama T; Seimo K; Kato T
J Urol; 2005 Nov; 174(5):1749-53. PubMed ID: 16217276
[TBL] [Abstract][Full Text] [Related]
15. De novo urothelial carcinoma in kidney transplantation patients with end-stage aristolochic acid nephropathy in China.
Li HZ; Xia M; Han Y; Xu XG; Zhang YS
Urol Int; 2009; 83(2):200-5. PubMed ID: 19752617
[TBL] [Abstract][Full Text] [Related]
16. Development of urologic de novo malignancies after renal transplantation.
Hevia V; Gómez V; Díez Nicolás V; Alvarez S; Gómez Del Cañizo C; Galeano C; Gomis A; García-Sagredo JM; Marcen R; Burgos FJ
Transplant Proc; 2014; 46(1):170-5. PubMed ID: 24507046
[TBL] [Abstract][Full Text] [Related]
17. Independent predictors of contralateral metachronous upper urinary tract transitional cell carcinoma after nephroureterectomy: multi-institutional dataset from three European centers.
Novara G; De Marco V; Dalpiaz O; Galfano A; Bouygues V; Gardiman M; Martignoni G; Patard JJ; Artibani W; Ficarra V
Int J Urol; 2009 Feb; 16(2):187-91. PubMed ID: 19054165
[TBL] [Abstract][Full Text] [Related]
18. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
19. Elective endoscopic management of transitional cell carcinoma first diagnosed in the upper urinary tract.
Thompson RH; Krambeck AE; Lohse CM; Elliott DS; Patterson DE; Blute ML
BJU Int; 2008 Nov; 102(9):1107-10. PubMed ID: 18522631
[TBL] [Abstract][Full Text] [Related]
20. Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.
Rouprêt M; Traxer O; Tligui M; Conort P; Chartier-Kastler E; Richard F; Cussenot O
Eur Urol; 2007 Mar; 51(3):709-13; discussion 714. PubMed ID: 16911852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
